{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:22:11Z","timestamp":1783128131185,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015732","name":"Bah\u00e7e\u015fehir University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014720","name":"Beirut Arab University","doi-asserted-by":"publisher","award":["BAP.2020 \\u2013 02.20"],"award-info":[{"award-number":["BAP.2020 \\u2013 02.20"]}],"id":[{"id":"10.13039\/501100014720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mrfmmm.2026.111939","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:59:21Z","timestamp":1778759961000},"page":"111939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors"],"prefix":"10.1016","volume":"833","author":[{"given":"Muhammed Deniz","family":"Oksal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turker","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timucin","family":"AVSAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2026.111939_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcp.2006.03.020","article-title":"Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells","volume":"72","author":"Merighi","year":"2006","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/417413","article-title":"VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2","volume":"2013","author":"Xu","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","article-title":"Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1\u03b1-ZEB1 axis","volume":"359","author":"Joseph","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-319-12048-5_2","article-title":"Glioma biology and molecular markers","volume":"163","author":"Cohen","year":"2015","journal-title":"Cancer Treat. Res"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10014-011-0077-6","article-title":"Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation","volume":"29","author":"Takano","year":"2012","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib6","first-page":"341","article-title":"A172 and T98G Cell Lines Characteristics","volume":"10","author":"Kiseleva","year":"2016"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12885-021-08150-7","article-title":"The expression and prognostic value of the epidermal growth factor receptor family in glioma","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1179\/016164105X39833","article-title":"Expression of VEGF and its receptors in different brain tumors","volume":"27","author":"Huang","year":"2005","journal-title":"Neurol. Res"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.718","article-title":"Genetic alterations of IDH1 and Vegf in brain tumors","volume":"7","author":"Veganzones","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/neuonc\/noy088","article-title":"IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas","volume":"20","author":"Zhang","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib13","first-page":"1","article-title":"Glial t\u00fcm\u00f6rlerin anjiogenezi","volume":"15","author":"K\u0131l\u0131\u00e7","year":"2005","journal-title":"T\u00fcrk N. \u00f6ro\u015firurji Derg."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib14","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1021\/acs.jmedchem.8b00305","article-title":"Novel modes of inhibition of wild-type isocitrate dehydrogenase 1 (IDH1): direct covalent modification of His315","volume":"61","author":"Jakob","year":"2018","journal-title":"J. Med Chem."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-019-03156-5","article-title":"Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours","volume":"143","author":"Sun","year":"2019","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib16","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.1007\/s11033-022-07750-1","article-title":"IDH1 mutation activates mTOR signaling pathway, promotes cell proliferation and invasion in glioma cells","volume":"49","author":"Avsar","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib17","doi-asserted-by":"crossref","DOI":"10.3791\/3040","article-title":"A matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells","author":"Francescone III","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib18","author":"Wimasis","year":"2016","journal-title":"WimTube Tube Form. Assay. Image Anal. Solut."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib20","first-page":"1","article-title":"BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib21","first-page":"3237","article-title":"The role of the 3D environment in hypoxia-induced drug and apoptosis resistance","volume":"31","author":"Kim","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib22","first-page":"362","article-title":"R132H mutation in IDH1 gene is associated with increased tumor HIF1-alpha and serum VEGF levels in primary glioblastoma multiforme","volume":"47","author":"Yalaza","year":"2017","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-022-07750-1","article-title":"IDH1 mutation activates mTOR signaling pathway, promotes cell proliferation and invasion in glioma cells","volume":"49","author":"Avsar","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib24","first-page":"1","article-title":"IDH1 mutation induces HIF-1\u03b1 and confers angiogenic properties in chondrosarcoma JJ012 cells","volume":"2022","author":"Hu","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10072-013-1607-2","article-title":"An IDH1 mutation inhibits growth of glioma cells via GSH depletion and ROS generation","volume":"35","author":"Shi","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/14728220902806444","article-title":"Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms","volume":"13","author":"Miletic","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.mrfmmm.2026.111939_bib27","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/ijms18061295","article-title":"EGFR and EGFRvIII promote angiogenesis and cell invasion in glioblastoma: combination therapies for an effective treatment","volume":"18","author":"Keller","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib28","first-page":"753","article-title":"The oncometabolite d-2-hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway","volume":"54","author":"Seok","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03009734.2012.665097","article-title":"PDGF and PDGF receptors in glioma","volume":"117","author":"Nazarenko","year":"2012","journal-title":"Ups. J. Med Sci."},{"key":"10.1016\/j.mrfmmm.2026.111939_bib30","first-page":"1","article-title":"Better prognosis of patients with glioma expressing FGF2-dependent PDGFRA irrespective of morphological diagnosis","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386196426000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386196426000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:02:13Z","timestamp":1783126933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386196426000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"alternative-id":["S1386196426000126"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2026.111939","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2026.111939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111939"}}